Two studies show that fewer men have been screened for prostate cancer using the PSA test since 2012, when a federal panel advised against routine screenings. With doctors increasingly questioning the test's validity, that's a good thing. But the real key is whether reduction in PSA testing has led to a rise in late-stage or fatal prostate cancer.
A new blood test that detects prostate cancer may send PSA formerly the gold standard of detection to the scrap heap. Not only does it involve a blood sample, rather than a biopsy, but the test also detects the deadly, aggressive form of the disease that PSA can miss entirely.
Because of the 1994 Dietary Supplement Health and Education Act (DSHEA), dietary supplement purveyors can't claim that their products can prevent, treat or cure disease. So they have to resort to "support" verbiage. But we know what they really mean.
A news report says Republican presidential candidate Ben Carson was associated with a supplement maker, and actually took a regimen of products to treat his prostate cancer diagnosis. After hearing his dubious views on vaccines during the debates, this latest discovery makes us feel even more uncomfortable about his commitment to sound science.
Are women driven by anti-science beliefs for how they choose their breast cancer treatment? No. But the Memorial Sloan Kettering and the Wall Street Journal seem to think so. They are basing this on a deeply flawed study by the hospital's media staff.
Since about 1990, the PSA blood test has been dramatically over-utilized as a screening test for prostate cancer. That changed in 2012 when a federal panel advised against its routine use. Now, a urologist says, let s try PSAs again. Really?
The American College of Physicians has come out with a report that questions the value of current screening recommendations and protocols. The report, released yesterday in the Annals of Internal Medicine, calls into question whether current screening practices exhibit high
Prostate cancer is the most common type of cancer in men. In 2015, there are expected to be 220,800 new cases of prostate cancer in the United States. Prostate cancer is the second leading cause of cancer death in American men (lung cancer is by far the leading cancer killer).
A study published in this month s Journal of Urology outlines a better than 90% effectiveness of dogs at detecting prostate cancer by sniffing a patient s urine. The researchers, based in Italy, trained two 3-year-old female German Shepherds for 5 months using operant
Sixty-five percent of those diagnosed with invasive cancer during 2003 to 2010 survived for five years or longer after their diagnosis, according to a recent report from the CDC. This is an increase from 64 percent fr
The latest in health news: Vitamin B supplementation could help reduce first stroke in adults with hypertension, strength training for the elderly key to good health, and cancer survival rates improving across the board
In an opinion piece published in today s New York Times, Dr. Richard J. Ablin addresses the serious problems with prostate cancer screening. Dr. Ablin discovered the prostate-specific antigen, or PSA, in 1970 (although widespread PSA screening didn t become routine until the 1990s) and it